Advanced search
Publication Cover
Acta Cardiologica Volume 72, 2017 - Issue 4
Submit an article Journal homepage
79
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Galectin-3 correlates with arrhythmogenic right ventricular cardiomyopathy and predicts the risk of ventricular ­arrhythmias in patients with implantable defibrillators

Fahrettin OzDepartment of Cardiology, Adana Numune Training and Research Hospital, Adana, Turkey;
, MD,
Imran OnurDepartment of Cardiology, Istanbul University, Istanbul School of Medicine, Istanbul, Turkey; Correspondence[email protected]
, MD,
Ali ElitokDepartment of Cardiology, Istanbul University, Istanbul School of Medicine, Istanbul, Turkey;
, MD,
Evin AdemogluDepartment of Biochemistry, Istanbul University, Istanbul School of Medicine, Istanbul, Turkey;
, PhD,
Ibrahim AltunDepartment of Cardiology, Mugla Sıtkı Kocman University, School of Medicine, Mugla, Turkey
, MD,
Ahmet Kaya BilgeDepartment of Cardiology, Istanbul University, Istanbul School of Medicine, Istanbul, Turkey;
&
Kamil AdaletDepartment of Cardiology, Istanbul University, Istanbul School of Medicine, Istanbul, Turkey;
, MD show all
Pages 453-459 | Received 31 Dec 2016, Accepted 24 Jan 2017, Published online: 14 Jul 2017

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Tayyar Akbulut, Faysal Saylik & Abdulcabbar Sipal. (2022) The association of galectin-3 level with ventricular arrhythmias and left ventricular strain in heart failure patients with implantable cardioverter defibrillator. Acta Cardiologica 77:7, pages 609-615.
Read now

Articles from other publishers (19)

Yasmin Mohtasham Kia, Alessandro Cannavo, Pegah Bahiraie, Sanam Alilou, Behrad Saeedian, Nastaran Babajani, Elina Ghondaghsaz, Amirmohammad Khalaji & Amir Hossein Behnoush. (2023) Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation. Disease Markers 2023, pages 1-13.
Crossref
Mireia Alcalde, Rocío Toro, Fernando Bonet, José Córdoba-Caballero, Estefanía Martínez-Barrios, Juan Antonio Ranea, Marta Vallverdú-Prats, Ramon Brugada, Viviana Meraviglia, Milena Bellin, Georgia Sarquella-Brugada & Oscar Campuzano. (2023) Role of microRNAs in arrhythmogenic cardiomyopathy: translation as biomarkers into clinical practice. Translational Research 259, pages 72-82.
Crossref
Yiyao Jiang, Xu Zhang, Ting Wei, Xianjie Qi, Isah Amir Abba, Nana Zhang, Yao Chen, Ran Wang & Chao Shi. (2022) Transcriptomic and ChIP-seq Integrative Analysis Identifies KDM5A-Target Genes in Cardiac Fibroblasts. Frontiers in Cardiovascular Medicine 9.
Crossref
N. N. Ilov, A. A. Nechepurenko & R. N. Shvartz. (2022) Predictive potential of blood biomarkers for subsequent ventricular tachyarrhythmias in patients with chronic heart failure and reduced left ventricular ejection fraction: review. Journal of Arrhythmology 29:2, pages 58-69.
Crossref
Ewa Smereczyńska-Wierzbicka, Radosław Pietrzak & Bożena Werner. (2022) A Scoping Review of Galectin-3 as a Biomarker of Cardiovascular Diseases in Pediatric Populations. International Journal of Environmental Research and Public Health 19:7, pages 4349.
Crossref
Deniz Akdis, Liang Chen, Ardan M. Saguner, Ningning Zhang, Joanna Gawinecka, Lanja Saleh, Arnold von Eckardstein, Jie Ren, Christian M. Matter, Zhenliang Hu, Xiao Chen, Felix C. Tanner, Robert Manka, Kai Chen, Corinna Brunckhorst, Jiangping Song & Firat Duru. (2022) Novel plasma biomarkers predicting biventricular involvement in arrhythmogenic right ventricular cardiomyopathy. American Heart Journal 244, pages 66-76.
Crossref
Shi Chen, Liang Chen, Firat Duru & Shengshou Hu. (2021) Heart Failure in Patients with Arrhythmogenic Cardiomyopathy. Journal of Clinical Medicine 10:20, pages 4782.
Crossref
Stephen P. Chelko & Jeffrey E. Saffitz. (2021) Role of galectin-3 in the pathogenesis of arrhythmogenic cardiomyopathy—It’s complicated. Heart Rhythm 18:8, pages 1404-1405.
Crossref
Marco Cason, Rudy Celeghin, Maria Bueno Marinas, Giorgia Beffagna, Mila Della Barbera, Stefania Rizzo, Carol Ann Remme, Connie R. Bezzina, Natascia Tiso, Barbara Bauce, Gaetano Thiene, Cristina Basso & Kalliopi Pilichou. (2021) Novel pathogenic role for galectin-3 in early disease stages of arrhythmogenic cardiomyopathy. Heart Rhythm 18:8, pages 1394-1403.
Crossref
Chiara Volani, Johannes Rainer, Vinicius Veri Hernandes, Viviana Meraviglia, Peter Paul Pramstaller, Sigurður Vidir Smárason, Giulio Pompilio, Michela Casella, Elena Sommariva, Giuseppe Paglia & Alessandra Rossini. (2021) Metabolic Signature of Arrhythmogenic Cardiomyopathy. Metabolites 11:4, pages 195.
Crossref
Nienke M. Stege, Rudolf A. de Boer, Maarten P. van den Berg & Herman H. W. Silljé. (2021) The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies. International Journal of Molecular Sciences 22:6, pages 2955.
Crossref
Angela Serena Maione, Ilaria Stadiotti, Chiara Assunta Pilato, Gianluca Lorenzo Perrucci, Valentina Saverio, Valentina Catto, Giulia Vettor, Michela Casella, Anna Guarino, Gianluca Polvani, Giulio Pompilio & Elena Sommariva. (2021) Excess TGF-β1 Drives Cardiac Mesenchymal Stromal Cells to a Pro-Fibrotic Commitment in Arrhythmogenic Cardiomyopathy. International Journal of Molecular Sciences 22:5, pages 2673.
Crossref
Radosław Pietrzak, Tomasz M. Książczyk, Elżbieta Górska, Łukasz A. Małek & Bożena Werner. (2021) Evaluation of Galectin-3 Plasma Concentration in Adolescents with Ventricular Arrhythmia. International Journal of Environmental Research and Public Health 18:5, pages 2410.
Crossref
Maria Bueno Marinas, Rudy Celeghin, Marco Cason, Gaetano Thiene, Cristina Basso & Kalliopi Pilichou. (2020) The Role of MicroRNAs in Arrhythmogenic Cardiomyopathy: Biomarkers or Innocent Bystanders of Disease Progression?. International Journal of Molecular Sciences 21:17, pages 6434.
Crossref
Jie Ren, Liang Chen, Ningning Zhang, Xiao Chen, Qian Zhao, Kai Chen, Xiangjie Li, Frank Ruschitzka, Firat Duru & Jiangping Song. (2020) Plasma testosterone and arrhythmic events in male patients with arrhythmogenic right ventricular cardiomyopathy. ESC Heart Failure 7:4, pages 1547-1559.
Crossref
Mi He, Wei‐Bo Zhao, My‐Nhan Nguyen, Helen Kiriazis, Yong‐Qin Li, Houyuan Hu & Xiao‐Jun Du. (2020) Association between heart rate variability indices and features of spontaneous ventricular tachyarrhythmias in mice. Clinical and Experimental Pharmacology and Physiology 47:7, pages 1193-1202.
Crossref
A. Zh. Gasparyan, N. B. Shlevkov & A. A. Skvortsov. (2020) Possibilities of modern biomarkers for assessing the risk of developing ventricular tachyarrhythmias and sudden cardiac death in patients with chronic heart failure. Kardiologiia 60:4, pages 101-108.
Crossref
Zornitsa Shomanova, Bernhard Ohnewein, Christiane Schernthaner, Killian Höfer, Christian A. Pogoda, Gerrit Frommeyer, Bernhard Wernly, Mathias C. Brandt, Anna-Maria Dieplinger, Holger Reinecke, Uta C. Hoppe, Bernhard Strohmer, Rudin Pistulli & Lukas J. Motloch. (2020) Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death. Journal of Clinical Medicine 9:2, pages 578.
Crossref
Ilaria Stadiotti, Giulio Pompilio, Angela Serena Maione, Chiara Assunta Pilato, Yuri D’Alessandra & Elena Sommariva. (2019) Arrhythmogenic cardiomyopathy: what blood can reveal?. Heart Rhythm 16:3, pages 470-477.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.